Ukko raises $40m Series B funding led by Leaps by Bayer and discloses a seasoned Advisory Board
– ISRAEL, Tel Aviv – Ukko, a biotech company with the mission to eliminate food allergies and sensitivities, today announced $40 million in new Series B funding led by Leaps by Bayer, joined by Continental Grain Company, PeakBridge Ventures, Skyviews Life Science, and Fall Line Capital, as well as existing investors Khosla Ventures, Innovation Endeavors, and TIME Ventures.…